The company incorporates the product into its Vascular Encapsulation Sonication Targeting (VESTTM) system that combines three FDA-approved elements: the Imagent
drugs, conventional ultrasound, plus an approved cancer drug.
Vesselon will use Imagent
to create novel therapeutic complexes in four classes of cancer drugs: cytokines, oncolytic viruses, monoclonal antibodies, and nucleic acid constructs.
"This agreement is important because it allows IMCOR to consider various alternatives for its Imagent
asset, including, seeking worldwide licensing partners for the continued development and marketing of Imagent
, engaging in a sale of some or all of this asset, or engaging in a merger or other material transaction."
is used in echocardiography, the most widely used imaging modality to diagnose heart disease.
M2 PHARMA-August 9, 2019-Vesselon acquires oncology drug Imagent